van der Molen, Aart J. https://orcid.org/0000-0002-2376-9424
van de Ven, Annick A. J. M.
Vega, Francisco
Dekkers, Ilona A.
Geenen, Remy W. F.
Bellin, Marie-France
Bertolotto, Michele
Brismar, Torkel B.
Clément, Olivier
Correas, Jean-Michel
Deike, Katerina
Heinz, Gertraud
Mahnken, Andreas H.
Mallio, Carlo A.
Quattrocchi, Carlo C.
Radbruch, Alexander
Reimer, Peter
Roditi, Giles
Romanini, Laura
Sebastià, Carmen
Stacul, Fulvio
Article History
Received: 30 October 2024
Revised: 27 April 2025
Accepted: 30 April 2025
First Online: 27 May 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr Aart J. van der Molen.
: The authors of this manuscript declare relationships with the following companies: A.J.v.d.M.: Guerbet. O.C.: Bracco Imaging, Guerbet, Bayer Healthcare. J.M.C.: Bracco Imaging, Guerbet. C.C.Q.: Bracco Imaging, Guerbet, Bayer Healthcare, GE Healthcare. A.R.: Bracco Imaging, Guerbet, Bayer Healthcare, GE Healthcare. M.F.B. is a member of the Advisory Editorial Board for European Radiology (European Society of Urogenital Radiology). T.B. is a member of the Scientific Editorial Board for European Radiology (Section Editor: Contrast Media). As such, they did not participate in the selection or review processes for this article. Medical Affairs specialists of the contrast media companies Bayer Healthcare, Bracco Imaging, GE Healthcare and Guerbet are consultants to the Contrast Media Safety Committee and participate in all scientific discussions but are not involved in the final recommendations.
: Basic statistics.
: Not applicable.
: Not applicable.
: Not applicable.
: